Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of gene variants in 30 patients from southeastern China with severe hypospadias by whole-exome sequencing. | Asian J Androl | 2026 | 41645416 | PubTator, text mining | PubMed |
| Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study. | PLoS One | 2026 | 41632717 | PubTator, text mining | PubMed |
| Bench to bedside: Bridging the gap. | Indian J Ophthalmol | 2026 | 41581029 | PubTator, text mining | PubMed |
| International clinical evidence-based guideline for Kleefstra syndrome. | Genet Med | 2026 | 41578867 | PubTator, text mining | PubMed |
| Do GLP-1 agonists affect perioperative risk in spine surgery? A systematic review and meta-analysis. | N Am Spine Soc J | 2026 | 41551027 | PubTator, text mining | PubMed |
| Digital Engagement Significantly Enhances Weight Loss Outcomes in Adults With Obesity Treated With Tirzepatide: Retrospective Cohort Study of a Digital Weight Loss Service. | J Med Internet Res | 2026 | 41538282 | PubTator, text mining | PubMed |
| Simultaneous epigenomic profiling and regulatory activity measurement using e2MPRA. | Nat Commun | 2026 | 41535307 | PubTator, text mining | PubMed |
| Therapeutic potential of prebiotics in modulating postprandial GLP-1, GLP-2, and glucose homeostasis in type 2 diabetes mellitus: Targeting gut dysbiosis and insulin resistance. | Diabetes Res Clin Pract | 2026 | 41534598 | PubTator, text mining | PubMed |
| AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications. | Sci Adv | 2026 | 41481731 | PubTator, text mining | PubMed |
| CtBP1/2 oligomerization promotes G9a-Mediated transcriptional repression. | J Biol Chem | 2026 | 41419197 | PubTator, text mining | PubMed |
| Analysis of factors influencing weight regain after bariatric-metabolic surgery in obesity hypoventilation syndrome patients based on gastrointestinal peptide hormones. | J Med Biochem | 2025 | 41799164 | PubTator, text mining | PubMed |
| Glioinflammation: disease-associated microglia and astrocytes in psychiatric disorders, neurodegeneration, and senescence. | Front Cell Neurosci | 2025 | 41783158 | PubTator, text mining | PubMed |
| Insights into salt adaptation from comparative genomics of Scirpus mariqueter and a related freshwater species. | Plant J | 2025 | 41396596 | PubTator, text mining | PubMed |
| Rodent home cage monitoring for preclinical safety pharmacology assessment: results of a multi-company validation evaluating nonclinical and clinical data from three compounds. | Front Toxicol | 2025 | 41267921 | PubTator, text mining | PubMed |
| Monogenic defects in Russian children with autism spectrum disorders. | World J Clin Pediatr | 2025 | 41255692 | PubTator, text mining | PubMed |
| A Simple Framework for Collaborative Development of Predictive Models Trained on Proprietary Data. | J Chem Inf Model | 2025 | 41253527 | PubTator, text mining | PubMed |
| Dual GIP/GLP1-RA, GCGR/GLP-1 RA and GLP1-RA for the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease with Type 2 Diabetes: A Systematic Review and Meta-analysis. | touchREV Endocrinol | 2025 | 41246119 | PubTator, text mining | PubMed |
| Interpretation guidance for MHRA regulatory considerations for phage therapeutic products. | Microbiology (Reading) | 2025 | 41230949 | PubTator, text mining | PubMed |
| JC Virus Agnogene Regulates Histone-Modifying Enzymes via PML-NBs: Transcriptomics in VLP-Expressing Cells. | Viruses | 2025 | 41157668 | PubTator, text mining | PubMed |
| Genetic Characterization of 128 Chinese Individuals with Neurodevelopmental Disorders via Whole-Exome Sequencing. | Dev Neurosci | 2025 | 41134724 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=3